Evidence map›Paper›PMID 37115287›Full record

ArticlePathologie (Heidelberg, Germany)2023

[Histological and molecular characteristics of tumours of the peripheral nervous system].

Patrick N Harter, Katharina J Weber, Michael W Ronellenfitsch

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Pathologie (Heidelberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Patrick N HarterZentrum für Neuropathologie und Prionforschung, Ludwig-Maximilians-Universität München, Feodor-Lynen Straße 23, 81377, München, Deutschland. patrick.harter@med.uni-muenchen.de.
Katharina J WeberNeurologisches Institut (Edinger Institut), Universitätsklinikum, Goethe Universität Frankfurt am Main, Frankfurt, Deutschland.
Michael W RonellenfitschDeutsches Konsortium für Translationale Krebsforschung (DKTK) Frankfurt/Mainz, Frankfurt, Deutschland.
Frankfurt Cancer Institute · DEGerman Cancer Research Center · DELudwig-Maximilians-Universität München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumours of the peripheral nervous system occur sporadically in adults and except for a minority of entities, these tumours are usually benign. The most common are nerve sheath tumours. Because these tumours grow in direct proximity or even invade peripheral nerve bundles, they can lead to severe pain and motion deficits. From the neurosurgical perspective these tumours are technically challenging, and especially for tumours with an invasive growth pattern complete resection may not be possible. Peripheral nervous system tumours that are associated with tumour syndromes such as neurofibromatosis type 1 and 2 or schwannomatosis are a particular clinical challenge. The goal of the current article is to present histological and molecular characteristics of peripheral nervous system tumours. Furthermore, future targeted therapy strategies are presented.

Indexed as

Nerve Sheath NeoplasmsNeurilemmomaNeurofibromatosesNeurofibromatosis 1Peripheral Nervous System NeoplasmsHumansNeoplastic syndromes, hereditaryNerve sheath neoplasmsNeurofibromatosis, type 1NeuropathologySchwannoma

Identifiers

PMID37115287
OpenAlexW4367316464

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.